Skip to main content
Clinical Trials/EUCTR2015-002537-22-AT
EUCTR2015-002537-22-AT
Active, not recruiting
Phase 1

Photodynamic therapy for skin rejuvenation: A pilotstudy evaluating theeffectiveness of 5-aminolevulinic acid -based photodynamic therapy in thetreatment of photodamaged skin - PDT with LED in treatment of photodamage

Medizinische Universität Wien, Univ. Klinik f. Dermatologie0 sites13 target enrollmentStarted: December 23, 2016Last updated:

Overview

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Medizinische Universität Wien, Univ. Klinik f. Dermatologie
Enrollment
13

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients between 40 and 80 with photodamaged skin and a photoaging
  • Score of 4 or more as well as skin type I\-III
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 10
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 3

Exclusion Criteria

  • Known allergy to aminlevulinic acid
  • Patients with porphyria or taking photosensitizing drugs
  • Patients with severe compromised general state
  • Patients with other dermatological diseases in the treatment area
  • Patient with another skin rejuvenation treatment in the last 6 moths
  • Patients unable to stick to the study protocol
  • Pregnant or lactating women
  • Patients who are participating in another study

Investigators

Sponsor
Medizinische Universität Wien, Univ. Klinik f. Dermatologie

Similar Trials

Active, not recruiting
Phase 1
Photodynamic therapy for skin rejuvenation: A study comparing two different methods for the treatment of sundamaged skiPhotodamaged skinMedDRA version: 20.0Level: PTClassification code 10068388Term: Actinic elastosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 20.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2017-003626-32-ATMedizinische Universität Wien, Univ. Klinik f. Dermatologie20
Not yet recruiting
Phase 2
Safety and efficacy of photodynamic therapy (with riboflavin as sensitizer) for treatment of malaria in adult Nigerian populatio
PACTR201912897645869Future Minds Development Initiative200
Active, not recruiting
Phase 1
Photodynamic therapy without curettageActinic keratosisMedDRA version: 20.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2017-001701-33-DKDepartment of Dermatology D92, Bispebjerg Hospital25
Completed
Phase 2
Assessment of the effect of photodynamic therapy on treatment of moderate-to-severe periodontitisChronic periodontitis.Chronic periodontitis
IRCT201512251760N44Vice chancellor for Research, Babol University of Medical Sciences30
Completed
Not Applicable
Clinical Effectiveness of photodynamic Therapy as an Adjunct to Nonsurgical Periodontal Treatmentmoderate to advanced chronic periodontitis.Chronic periodontitis
IRCT2015022221180N1Dental Research Center,Research Institue of Dental Science,Shahid Beheshti University of Medical Sci18